Evoke Pharma (EVOK) Tops Q4 EPS by 20c

Evoke Pharma (NASDAQ: EVOK) reported Q4 EPS of ($0.48), $0.20 better than the analyst estimate of ($0.68).

For earnings history and earnings-related data on Evoke Pharma (EVOK) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Vivos Therapeutics posts 35% revenue gain but widens net loss
• Pro Diversity Network (IPDN) Reports Q2 Loss of $0.15